• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

OptiCept Technologies

2.90 SEK

+5.45 %

Less than 1K followers

OPTI

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+5.45 %
+60.40 %
+42.16 %
+13.28 %
+10.69 %
-34.61 %
-69.27 %
-93.20 %
-42.49 %

OptiCept Technologies provides the food and plant industry with technological solutions that are used to increase the sustainability of various raw materials. The company works with biological processes that provide increased extraction from the raw material, reduced waste and maintained taste, aroma, color, nutritional content. The company has a patented technology within PEF (pulsed electric field) and VI (Vacuum Infusion). The company sells its products on a global level. The headquarters are located in Lund.

Read more
Market cap
248.82M SEK
Turnover
498.34K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Research
Press releases
3rd party
ShowingAll content types

Forum discussions
OptiCept Technologies develops and provides technological solutions specifically designed for the needs of the food and plant industries. The company’s technologies focus on improving the sustainability and utilization of raw materials, enabling more efficient production while reducing...
8/31/2024, 12:07 PM
by Sijoittaja-alokas
3
@lucas.mattsson on tehnyt uuden analyysin OptiCeptistä. The capital raise announced on Friday reduces the financing risks and secures the company’s financing until the end of 2025. Due to the overall structure of the raise, we expect it to succeed. With short-term financing in check...
10/21/2024, 4:24 PM
by Sijoittaja-alokas
1
Here are @lucas.mattsson’s comments on OptiCept’s capital raise preliminarily reaching 70 percent of their subscription target, which maintains the company’s cash flow at nearly the expected level. Inderes OptiCept’s capital raise preliminary outcome at 70% of maximum gross proceeds...
11/27/2024, 11:36 AM
by Sijoittaja-alokas
0
OptiCept has signed a rental agreement with the Central American company Mexifrutas for the rental of an OptiCept PEF system to enhance pineapple juice extraction. A successful evaluation period could lead to long-term cooperation and help expand OptiCept’s commercial operations ...
10/16/2024, 6:45 PM
by Sijoittaja-alokas
0
OptiCept on ilmoittanut, että sen asiakas La Salud on saanut taloudellista tukea EU:lta, mikä oli tärkeä edellytys aiemmin tiedotetun kahden OliveCept-järjestelmän tilauksen etenemiselle. Tässä olisi Lucaksen kommentit asiaan liittyen. OptiCept has announced that its customer, La...
9/18/2024, 1:54 PM
by Sijoittaja-alokas
0
Here are Lucas’s comments regarding the options. OptiCept has reached an agreement to bring forward the exercise period for all outstanding warrants, resulting in the subscription of 4,350,000 shares worth around 13 MSEK. We had previously flagged that this was a possibility, so ...
9/12/2024, 7:50 AM
by Sijoittaja-alokas
0
Here are Lucas Mattsson’s comments on OptiCept signing a letter of intent (LOI) with Saab to explore a long-term partnership in Thailand aimed at improving productivity in the food and forestry industries. The cooperation could lead to new orders and a wider commercial scale in the...
9/9/2024, 10:19 PM
by Sijoittaja-alokas
0
Read more on our forum
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
28.8.
2026

Interim report Q2'26

28.11.
2026

Interim report Q3'26

5.3.
2027

Annual report '26

Press release6/3/2026, 6:45 AM

OptiCept - New order for FPS in the Netherlands

OptiCept Technologies
Press release6/2/2026, 6:55 AM

DNB Carnegie Access: OptiCept Technologies: The path to positive EBITDA is paved – Q1 review

OptiCept Technologies
Press release6/1/2026, 12:00 PM

Interview with FPS

OptiCept Technologies

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Press release5/29/2026, 6:30 AM

OptiCept - New order for FPS USA

OptiCept Technologies
Regulatory press release5/29/2026, 6:00 AM

OptiCept Technologies AB (Publ) Interim Report for the first quarter 2026

OptiCept Technologies
Press release5/25/2026, 6:00 AM

OptiCept part of new major order for FPS

OptiCept Technologies
Regulatory press release5/21/2026, 9:30 AM

Bulletin from annual general meeting of OptiCept Technologies AB (publ) on 21 May 2026

OptiCept Technologies
Press release5/13/2026, 12:30 PM

PM: Change of Chairman of the Board – OptiCept Technologies AB

OptiCept Technologies
Press release5/6/2026, 7:15 AM

OptiCept Technologies AB (publ) - The first license fee from FPS and the stock sale has been paid. Revenue amounts to SEK 21 million.

OptiCept Technologies
Press release3/31/2026, 4:29 AM

DNB Carnegie Access: OptiCept Technologies: Stage set for transformational 2026 – Q4 review

OptiCept Technologies
Press release3/30/2026, 7:00 AM

DNB Carnegie Access: Opticept - Q4 2025 - intervju

OptiCept Technologies
Regulatory press release3/27/2026, 7:00 AM

OptiCept Technologies Year-End Report Q4 2025

OptiCept Technologies
Regulatory press release3/18/2026, 8:30 AM

OptiCept carries out previously announced directed issue of shares to lenders and provider of a credit facility following a request for early conversion totalling approx. SEK 44.4 million

OptiCept Technologies
Press release3/16/2026, 7:30 AM

New Development Opportunities for OptiCept

OptiCept Technologies
Press release3/13/2026, 7:30 AM

OptiCept Strengthens Its Balance Sheet and Targets Profitability in the Second Half of 2026

OptiCept Technologies
Press release3/12/2026, 10:30 AM

OptiCept Signs Global Licensing Agreement with FPS – What Does This Mean for the Company?

OptiCept Technologies
Press release3/9/2026, 8:47 AM

DNB Carnegie Access: OptiCept Technologies: FPS to get partial foods exclusivity, loans to be converted

OptiCept Technologies
Press release2/3/2026, 1:50 PM

OptiCept Implements Further Savings

OptiCept Technologies
Regulatory press release2/3/2026, 1:45 PM

OptiCept implements changes to the management team

OptiCept Technologies
Press release2/2/2026, 7:55 AM

OptiCept Receives Additional Order via FPS Food Process Solutions

OptiCept Technologies